hero section gradient
16 handpicked stocks

Meta AI Pivot Could Boost Tech Supply Chain in 2025

Meta is significantly reducing its investment in the metaverse to focus on the more promising field of artificial intelligence. This strategic shift could boost companies that are critical to the AI supply chain, from chipmakers to software developers.

Author avatar

Han Tan | Market Analyst

Published on January 13

Your Basket's Financial Footprint

This basket's total market capitalisation is 18,614,021.68 and is heavily anchored by several very large-cap stocks, giving it a concentrated, large-cap profile that tends to be less volatile than smaller-cap baskets.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility, offering greater stability and closer tracking of broad market moves.
  • Suitable as a core holding for long-term allocation, not as a short-term speculative trade.
  • Expect steady, long-term value appreciation rather than rapid, short-term explosive gains.
Total Market Cap
  • NVDA: $4.49T

  • META: $1.62T

  • MSFT: $3.55T

  • Other

About This Group of Stocks

1

Our Expert Thinking

Meta's significant pivot from metaverse investments to artificial intelligence signals a broader industry shift. This reallocation of billions towards AI creates substantial opportunities for companies across the entire AI value chain, from chip manufacturers to cloud providers.

2

What You Need to Know

This group spans the complete AI ecosystem - semiconductor designers, data centre infrastructure providers, cloud computing giants, and AI software specialists. These companies are positioned to benefit directly from increased investment as tech leaders prioritise AI over speculative projects.

3

Why These Stocks

Each stock was handpicked by professional analysts for its critical role in the AI supply chain. From NVIDIA's essential GPUs to Microsoft's Azure platform, these companies provide the foundational technology that makes artificial intelligence possible.

Why You'll Want to Watch These Stocks

🔄

Industry Giant's Strategic Shift

Meta's pivot from metaverse to AI represents a massive capital reallocation that could benefit the entire AI supply chain. When tech giants change direction, opportunities follow.

🏗️

Foundation of the AI Revolution

These companies provide the essential building blocks for AI - from the chips that power machine learning to the cloud platforms that deliver AI services to millions.

🎯

Professional Analyst Selection

Each stock was carefully chosen by experts for its critical role in the AI ecosystem. This isn't random selection - it's strategic exposure to AI's most important players.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Beverage Stocks: What's Next After Coca-Cola's Pivot

Beverage Stocks: What's Next After Coca-Cola's Pivot

Coca-Cola is discontinuing its historic Minute Maid frozen products to focus on faster-growing beverage categories. This strategic shift highlights a broader investment opportunity in companies leading the market's transition toward healthier, more convenient, and functional drinks.

Factory Automation Stocks | Rising Labor Costs Trend

Factory Automation Stocks | Rising Labor Costs Trend

Volkswagen's recent agreement with the UAW signals a new era of rising labor costs for foreign automakers in the U.S. This theme focuses on companies poised to benefit as the industry increases investment in factory automation and robotics to enhance productivity.

Blood Thinner Breakthrough Explained | Market Overview

Blood Thinner Breakthrough Explained | Market Overview

Bayer's successful Phase III trial for its new blood thinner has demonstrated a significant reduction in stroke recurrence. This breakthrough positions the company favorably against competitors and highlights an investment opportunity in the evolving landscape of cardiovascular treatments.

Frequently Asked Questions